Latest News from PET
Yale Radiology and Psychiatry Researchers Join with Penn Medicine to Create a New Center to Study Opioid Use Disorders
Opioid use disorder has reached epidemic levels in the United States. Over the last two decades, opioid-related overdose deaths increased by more than 50 percent, with nearly 50,000 in 2018, according to the Centers for Disease Control and Prevention. Researchers from Yale School of Medicine (YSM) and Penn Medicine, which comprises the Perelman School of Medicine at the University of Pennsylvania, have created a new center that focuses on neuroimaging to improve our understanding of opioid use disorders and find new treatments.
- August 19, 2019
Yihuan Lu, PhD, Associate Research Scientist, Yale University PET Center, has been awarded a Small Research R03 grant from the National Institutes of Health (NIH) for his project entitled, "Data-Driven Simultaneous Respiratory and Body Motion Correction for PET/CT.”
- August 13, 2019
Zhengxin (Jason) Cai, PhD, Assistant Professor, Yale University PET Center, has been awarded an Exploratory/Development R21 grant from the National Institutes of Health (NIH). Dr. Cai’s research project titled, "Development of BBB Permeable PD-L1 PET Imaging Agents,” will involve synthesis and radiolabeling a library of small molecule PD-L1 ligands as potential PET imaging probes, aiming to find one probe that could penetrate the blood-brain barrier (BBB) and allow for the quantification of PD-L1 in brain tumor or metastasis.
- August 12, 2019
Nabeel Nabulsi, PhD, Deputy Director of Chemistry; Chief of Quality Control and Regulatory Affairs, and Songye Li, PhD, Associate Research Scientist, Yale University PET Center, were invited by Dr. Xiaoai Wu to serve as Guest Lecturers for the Department of Nuclear Medicine, West China Hospital, Sichuan University (June 2019). Nabulsi’s presentation focused on quality assurance, quality control and compliance with regulatory requirements during radiotracer production. Li discussed PET Center research on the development of novel 18F-labelled SV2A radiotracers for imaging synaptic density in the living human brain, and the development of 18F-labelled 11β-HSD1radiotracers and translation into human use.
- August 12, 2019
Songye Li, PhD receives first-place prize in Basic Science at SNMMI 2019 and wins Young Investigator Award
Dr. Songye Li’s abstract, entitled, “First-in-human Evaluation of 18F-SDM-8, A Novel Radiotracer for PET Imaging of Synaptic Vesicle Glycoprotein 2A,” was awarded the first-place prize in Basic Science by the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Early Career Professionals Committee at the SNMMI annual meeting in Anaheim, CA, June 2019. In the same conference, Dr. Li’s presentation on the above abstract won a Young Investigator Award from the Brain Imaging Council.
- August 07, 2019
The Journal of Nuclear Medicine Front Cover (August 1, 2019) features PET research in radiotracer evaluation of 11C-AS2471907 in the human brain conducted by Jean-Dominique Gallezot, PhD and colleagues at the Yale PET Center. Also featured is a translational research study in radiotracer evaluation of 11C-LSN3172176 conducted by Nabeel Nabulsi, PhD, and Yale PET colleagues.
- June 24, 2019
Jason Bini, PhD, awarded NIDDK Development Grant for PET research on cortisol metabolism and obesity
Jason Bini, PhD, Associate Research Scientist, Yale University PET Center, has been awarded a K01 Research Scientist Development Award by the National Institute of Diabetes and Digestive and Kidney Diseases
- June 17, 2019
Takuya Toyonaga, Xiaotian Fang, and Pragalath Sadasivam were awarded Early Career Investigator travel awards by the International Society for Cerebral Blood Flow & Metabolism (ISCBFM) to attend the BRAIN & BRAIN PET conference in Yokohama, Japan.
- May 31, 2019
Yasmin Zakiniaeiz, PhD, National Institute of Drug Abuse (NIDA) T32 Postdoctoral Fellow, was awarded the NIDA Director’s Travel Award to attend the 81st Annual College on Problems of Drug Dependence (CPDD) 2019 Meeting in San Antonio, Texas.
- May 23, 2019
WHRY announces funding for first-of-their-kind studies on pain relief, cannabis, and the genetic basis of sex differences across a broad range of ailments, including Alzheimer’s disease and heart disease.